STEVE L CORDER
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- WHEELING, WV
- NPI
- 1184726804
- Received
- $57,201 in 774 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 130 | $10,266 |
| 2024 | General payment | 139 | $17,267 |
| 2023 | General payment | 77 | $2,048 |
| 2022 | General payment | 117 | $2,043 |
| 2021 | General payment | 137 | $8,812 |
| 2020 | General payment | 86 | $8,469 |
| 2019 | General payment | 88 | $8,293 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 166 | $45,378 | 2019–2025 |
| ABBVIE INC. | 102 | $1,875 | 2021–2025 |
| Vanda Pharmaceuticals Inc. | 85 | $1,579 | 2019–2025 |
| Alkermes, Inc. | 80 | $1,558 | 2019–2025 |
| Neurocrine BioSciences, Inc. | 80 | $1,505 | 2019–2025 |
| Janssen Pharmaceuticals, Inc | 53 | $1,009 | 2019–2025 |
| Otsuka America Pharmaceutical, Inc. | 41 | $957 | 2019–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 45 | $835 | 2020–2025 |
| Indivior Inc. | 24 | $472 | 2022–2025 |
| Sunovion Pharmaceuticals Inc. | 32 | $421 | 2019–2021 |
| Janssen Scientific Affairs, LLC | 2 | $400 | 2024–2025 |
| Lundbeck LLC | 17 | $302 | 2020–2025 |
| E.R. Squibb & Sons, L.L.C. | 13 | $264 | 2024–2025 |
| Axsome Therapeutics, Inc. | 4 | $169 | 2023–2025 |
| Avanir Pharmaceuticals, Inc. | 8 | $137 | 2019–2022 |
| Noven Therapeutics, LLC | 6 | $95 | 2021–2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 | 2021 |
| Allergan, Inc. | 5 | $70 | 2019–2020 |
| Merck Sharp & Dohme LLC | 3 | $39 | 2020–2021 |
| Braeburn Inc. | 1 | $17 | 2025 |
| ACADIA Pharmaceuticals Inc | 1 | $17 | 2020 |
| Sage Therapeutics, LLC | 1 | $14 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 24 | $35,548 |
| Food and Beverage | 716 | $15,170 |
| Consulting Fee | 4 | $3,130 |
| Travel and Lodging | 18 | $2,734 |
| Education | 12 | $618 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | Braeburn Inc. | $17 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-12-16 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $5 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-10 | Vanda Pharmaceuticals Inc. | $2 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-30 | Teva Pharmaceuticals USA, Inc. | $296 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-20 | Axsome Therapeutics, Inc. | $66 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-20 | Vanda Pharmaceuticals Inc. | $8 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-19 | Indivior Inc. | $14 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-11-19 | Neurocrine BioSciences, Inc. | $11 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-18 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-17 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | Vanda Pharmaceuticals Inc. | $4 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-04 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-10-31 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-22 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-22 | Vanda Pharmaceuticals Inc. | $6 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-21 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2025 | |
| 2025-10-15 | Indivior Inc. | $16 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-10-14 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-13 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-07 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-01 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-26 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-23 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-22 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-09-22 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-19 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-16 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-15 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-11 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-10 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-09 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-09 | Vanda Pharmaceuticals Inc. | $5 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | Vanda Pharmaceuticals Inc. | $33 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-08-28 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-26 | Neurocrine BioSciences, Inc. | $10 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-25 | Teva Pharmaceuticals USA, Inc. | $330 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | Teva Pharmaceuticals USA, Inc. | $2,183 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-21 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-21 | Teva Pharmaceuticals USA, Inc. | $71 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-21 | Teva Pharmaceuticals USA, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-19 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-19 | E.R. Squibb & Sons, L.L.C. | $32 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-12 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-11 | Teva Pharmaceuticals USA, Inc. | $27 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-11 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-11 | Neurocrine BioSciences, Inc. | $7 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-31 | Teva Pharmaceuticals USA, Inc. | $672 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-31 | Alkermes, Inc. | $25 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-07-31 | Alkermes, Inc. | $14 | Education | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-07-28 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-23 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-17 | Teva Pharmaceuticals USA, Inc. | $1,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-07-17 | Teva Pharmaceuticals USA, Inc. | $116 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-07-17 | Teva Pharmaceuticals USA, Inc. | $49 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-07-17 | Vanda Pharmaceuticals Inc. | $34 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-07-16 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-09 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | Vanda Pharmaceuticals Inc. | $4 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-07-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-24 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-18 | Indivior Inc. | $27 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-06-17 | Teva Pharmaceuticals USA, Inc. | $29 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-17 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-11 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-06-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-04 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-29 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-20 | Teva Pharmaceuticals USA, Inc. | $99 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-19 | Alkermes, Inc. | $34 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-05-17 | ABBVIE INC. | $80 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-05 | Indivior Inc. | $25 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-05-05 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-01 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-30 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-29 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-04-24 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-22 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-04-15 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-15 | Sage Therapeutics, LLC | $14 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, PSYCHIATRY/PSYCHOLOGY | 2025 | |
| 2025-04-14 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-08 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-31 | Alkermes, Inc. | $7 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-03-30 | Teva Pharmaceuticals USA, Inc. | $2,074 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-03-26 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-26 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-19 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-11 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-11 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-10 | Indivior Inc. | $18 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-03-05 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-02-26 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-26 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-20 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-18 | Indivior Inc. | $24 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-02-14 | Janssen Scientific Affairs, LLC | $200 | Consulting Fee | Cash or cash equivalent | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-02-13 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-02-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-10 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-05 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-27 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-22 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2025 | |
| 2025-01-22 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Neurocrine BioSciences, Inc. | $105 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-13 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-07 | Indivior Inc. | $25 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-01-07 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-16 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-10 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-26 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-11-21 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-19 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-18 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2024 | |
| 2024-11-18 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-11-13 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-11-12 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-11-07 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-05 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-30 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-29 | Alkermes, Inc. | $14 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-10-28 | Indivior Inc. | $26 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-10-24 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2024 | |
| 2024-10-23 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-22 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-21 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-17 | Teva Pharmaceuticals USA, Inc. | $570 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-10-09 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-30 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-25 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-12 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-12 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-10 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-09-10 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-09 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-04 | Teva Pharmaceuticals USA, Inc. | $1,425 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-09-04 | Teva Pharmaceuticals USA, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-09-04 | Teva Pharmaceuticals USA, Inc. | $37 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-09-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-19 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-08-15 | Teva Pharmaceuticals USA, Inc. | $570 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-08-15 | Janssen Pharmaceuticals, Inc | $28 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2024 | |
| 2024-08-14 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-08-14 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-13 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-08-12 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-07 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-06 | Teva Pharmaceuticals USA, Inc. | $1,853 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-08-06 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-08-06 | Teva Pharmaceuticals USA, Inc. | $95 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-06 | Teva Pharmaceuticals USA, Inc. | $9 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-08-01 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-31 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-25 | Indivior Inc. | $32 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-07-24 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2024 | |
| 2024-07-23 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-18 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-07-17 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-07-03 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-07-02 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-27 | Teva Pharmaceuticals USA, Inc. | $840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-06-26 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-20 | Indivior Inc. | $21 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-06-18 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-13 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-06-11 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-06-10 | Teva Pharmaceuticals USA, Inc. | $112 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-29 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-29 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-23 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-22 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA Drug, Neuroscience | 2024 | |
| 2024-05-20 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-20 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-05-14 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-05-14 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 |
The latest 200 records of 774.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Wheeling, WV, county Ohio County, WV, state West Virginia; placed by its city name.
| Measure | Place (city or town) Wheeling, WV | County Ohio County, WV | State West Virginia |
|---|---|---|---|
| Population B01003 | 26,350 | 41,582 | 1,778,373 |
| Population, 2020 census P1 | 27,052 | 42,425 | 1,793,716 |
| Median age B01002 | 45.4 | 42.7 | 42.7 |
| Under 18 B01001 | 18.1% | 19.4% | 20.0% |
| 65 and over B01001 | 25.9% | 22.8% | 21.0% |
| Households B11001 | 12,614 | 18,342 | 728,655 |
| Foreign born B05002 | 2.1% | 2.5% | 1.8% |
| Median household income B19013 | $48,590 | $57,094 | $59,608 |
| Median family income B19113 | $84,331 | $89,198 | $77,710 |
| Per capita income B19301 | $36,509 | $38,134 | $34,203 |
| Poverty rate B17001 | 20.5% | 17.7% | 16.7% |
| Unemployment rate B23025 | 6.5% | 6.0% | 5.4% |
| Civilian labor force B23025 | 12,344 | 20,006 | 786,889 |
| Mean commute (minutes) B08013 | 19.8 | 21.1 | 26.6 |
| Bachelor's degree or higher B15003 | 34.1% | 33.9% | 24.1% |
| Housing units B25001 | 14,569 | 21,120 | 861,325 |
| Owner-occupied B25003 | 59.8% | 66.4% | 74.9% |
| Renters B25003 | 40.2% | 33.6% | 25.1% |
| Median home value B25077 | $146,500 | $166,000 | $162,600 |
| Median gross rent B25064 | $794 | $821 | $872 |
| White, not Hispanic B03002 | 88.8% | 89.8% | 89.7% |
| Black B03002 | 4.5% | 3.3% | 3.1% |
| Hispanic or Latino B03002 | 1.4% | 1.7% | 2.1% |
| Asian B03002 | 0.4% | 0.5% | 0.8% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Wheeling, WV.
Comments